Showing results (111-120 of 122) with videos related to

Sort By:
Pageof 13
Journal of Diabetes Science and Technology|March 18, 2024
Cost-Effectiveness of Closed-Loop Automated Insulin Delivery Using the Cambridge Hybrid Algorithm in Children and Adolescents with Type 1 Diabetes: Results from a Multicenter 6-Month Randomized TrialD Steven Fox, Julia Ware, Charlotte K Boughton, et al.
Diabetes Care|June 23, 2016
Outcome Measures for Artificial Pancreas Clinical Trials: A Consensus ReportDavid M Maahs, Bruce A Buckingham, Jessica R Castle, et al.
Diabetes Technology & Therapeutics|March 10, 2021
Predictors of Time-in-Range (70-180 mg/dL) Achieved Using a Closed-Loop Control SystemMelissa J Schoelwer, Lauren G Kanapka, R Paul Wadwa, et al.
Diabetes Care|May 12, 2009
The effect of continuous glucose monitoring in well-controlled type 1 diabetes, Roy W Beck, Irl B Hirsch, et al.
Diabetes, Obesity & Metabolism|July 15, 2022
Lived experience of CamAPS FX closed loop system in youth with type 1 diabetes and their parentsKorey K Hood, Natasha Garcia-Willingham, Sarah Hanes, et al.
Journal of Diabetes Science and Technology|July 1, 2025
Early Stages of Automated Insulin DeliveryHoward Zisser, Roman Hovorka, Ananda Basu, et al.
Diabetes Technology & Therapeutics|July 1, 2025
Early Stages of Automated Insulin DeliveryHoward Zisser, Roman Hovorka, Ananda Basu, et al.
Diabetes Care|November 23, 2017
International Consensus on Use of Continuous Glucose MonitoringThomas Danne, Revital Nimri, Tadej Battelino, et al.
The Lancet. Diabetes & Endocrinology|December 9, 2022
Continuous glucose monitoring and metrics for clinical trials: an international consensus statementTadej Battelino, Charles M Alexander, Stephanie A Amiel, et al.
Diabetes Care|June 10, 2019
Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in RangeTadej Battelino, Thomas Danne, Richard M Bergenstal, et al.
Pageof 13